Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma
Life · 09.02.2024 · 14 (2) · 245
DOI: 10.3390/life14020245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 09.02.2024. Verfasst von Roberto Mazzetto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padova, Italy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The interleukins IL-4 and IL-13 are increasingly recognized contributors to the pathogenesis of cutaneous T cell lymphomas (CTCLs), and their role in disease-associated pruritus is accepted. The prevailing Th2 profile in advanced CTCL underscores the significance of understanding IL-4/IL-13 expression dynamics from the early stages of disease, as a shift from Th1 to Th2 may explain CTCL progression. Targeted agents blocking key cytokines of type 2 immunity are established therapeutics in atopic disorders and have a promising therapeutic potential in CTCL, given their involvement in cutaneous symptoms and their contribution to the pathogenesis of disease. IL-4, IL-13, and IL-31 are implicated in pruritus, offering therapeutic targets with dupilumab, tralokinumab, lebrikizumab, and nemolizumab. This review analyzes current knowledge on the IL-4/IL-13 axis in mycosis fungoides and Sezary syndrome, the most common types of CTCL, examining existing literature on the pathogenetic implications with a focus on investigational treatments. Clinical trials and case reports are required to shed light on novel uses of medications in various diseases, and ongoing research into the role of IL-4/IL-13 axis blockers in CTCL therapy might not only improve the management of disease-related pruritus but also provide in-depth insights on the pathophysiologic mechanisms of CTCL.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padova, Italy.
ORCID-Profile: Roberto Mazzetto, Jacopo Tartaglia, Christian Ciolfi, Alvise Sernicola
Zitieren
APA
Mazzetto, R., Miceli, P., Tartaglia, J., Ciolfi, C., Sernicola, A., & Alaibac, M. (2024). Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma. Life, 14(2), 245. https://doi.org/10.3390/life14020245
Vancouver
Mazzetto R, Miceli P, Tartaglia J, Ciolfi C, Sernicola A, Alaibac M. Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma. Life. 2024;14(2):245. doi:10.3390/life14020245
BibTeX
@article{Mazzetto2024,
author = {Mazzetto, Roberto and Miceli, Paola and Tartaglia, Jacopo and Ciolfi, Christian and Sernicola, Alvise and Alaibac, Mauro},
title = {Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma},
journal = {Life},
year = {2024},
volume = {14},
number = {2},
pages = {245},
doi = {10.3390/life14020245}
}
EUVIMED